Abstract
Drug abuse has spread quickly since reemerging as a national problem in China in the late 1980s. The number of registered drug abusers increased from 70 000 in 1990 to more than one million by the end of 2004. In addition to opioids, abuse of “new” types of drugs including 3,4-methylenedioxymethamphetamine (MDMA) and ketamine has spread since 1997. Illicit drug trafficking and production have swept most of southern China, and throughout the country drug abuse has caused many problems for both abusers and the community. One major drug-related problem is the spread of HIV, which has caused major social and economic damage in China. In response, the Chinese government has begun an anti-drug campaign, including legislative measures to control drug abuse. However, changing the public's attitudes toward drug abusers and breaking the link between drug use and HIV spread are equally important.
Similar content being viewed by others
Article PDF
References
Lowinger P . How the People's Republic of China solved the drug abuse problem. Am J Chin Med 1973; 1: 275–82.
Lowinger P . The solution to narcotic addiction in the People's Republic of China. Am J Drug Alcohol Abuse 1977; 4: 165–78.
Zhao C, Liu Z, Zhao D, Liu Y, Liang J, Tang Y, et al. Drug abuse in China. Ann NY Acad Sci 2004; 1025: 439–45.
National Institute on Drug Dependence and Drug Abuse Surveillance Center. Report of drug surveillance 2002. Beijing: NDASC, NIDD; 2002.
Kulsudjarit K . Drug problem in southeast and southwest Asia. Ann NY Acad Sci 2004; 1025: 446–57.
Kaufman J, Jing J . China and AIDS: the time to act is now. Science 2002; 296: 2339–40.
National Anti-drug Committee. Anti-drug forum July, 2004; 7–9, Beijing.
National Institute on Drug Dependence and Drug Abuse Surveillance Center. Report of drug surveillance 2003. Beijing: NDASC, NIDD; 2003.
National Institute on Drug Dependence and National Drug Abuse Surveillance Center. Report of drug surveillance 2004. Beijing: NDASC, NIDD; 2004.
Li F . Education, prevention crucial to drug control. China Daily; June, 26 2004. Beijing, China.
China UN Theme Group on HIV/AIDS for the UN Country Team in China. HIV/AIDS: China's titanic peril (2001 Update of the AIDS situation and needs assessment report). Beijing: UNAIDS; 2001.
Jing J, Zhang Y . HIV/AIDS and China's ethnic groups. In: Workshop on Changing Health Needs and Reproductive Health Services; 2002 June 4, Beijing. Beijing: China Health Economics Institute, Ministry of Health.
China-UK Workshop on HIV/AIDS in China. Annual report of China-UK HIV/AIDS Prevention and Care Project. Beijing: China-UK Workshop on HIV/AIDS in China; 2004.
Lau JT, Kim JH, Tsui HY . Prevalence, health outcomes, and patterns of psychotropic substance use in a Chinese population in Hong Kong: a population-based study. Subst Use Misuse 2005; 40: 187–20.
Aceijas C, Stimson GV, Hickman M, Rhodes T . Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18: 2295–303.
Morton J . Ecstasy: pharmacology and neurotoxicity. Curr Opin Pharmacol 2005; 5: 79–86.
Parrott AC . MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology 2004; 50: 329–35.
Hanson GR, Rau KS, Fleckenstein AE . The methamphetamine experience: a NIDA partnership. Neuropharmacology 2004; 47 Suppl 1: 92–100.
Chung H, Park M, Hahn E, Choi H, Choi H, Lim M . Recent trends of drug abuse and drug-associated deaths in Korea. Ann NY Acad Sci 2004; 1025: 458–64.
Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF . Overland heroin trafficking routes and HIV-1 spread in south and southeast Asia. AIDS 2000; 14: 75–83.
Hao W, Xiao S, Liu T, Young D, Chen S, Zhang D, et al. The second National Epidemiological Survey on illicit drug use at six high-prevalence areas in China: prevalence rates and use patterns. Addiction 2002; 97: 1305–15.
Yang H, Li X, Stanton B, Liu H, Liu H, Wang N, Fang X, et al. Heterosexual transmission of HIV in China: a systematic review of behavioral studies in the past two decades. Sex Transm Dis 2005; 32: 270–80.
Zeng Y . HIV infection and AIDS in China. Arch AIDS Res 1992; 6: 1–5.
Ruan Y, Qin G, Liu S, Qian H, Zhang L, Zhou F, et al. HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China. J Acquir Immune Defic Syndr 2005; 39: 459–63.
Kerr C . Sexual transmission propels China's HIV epidemic. Lancet Infect Dis 2005; 5: 474.
Lau JT, Feng T, Lin X, Wang Q, Tsui HY . Needle sharing and sex-related risk behaviours among drug users in Shenzhen, a city in Guangdong, southern China. AIDS Care 2005; 17: 166–81.
Lu L, Chen H, Su W, Ge X, Yue W, Su F, et al. Role of withdrawal in reinstatement of morphine-conditioned place preference. Psychopharmacology 2005; 181: 90–100.
Lu L, Dempsey J . Cocaine seeking over extended withdrawal periods in rats: time dependent increases of responding induced by heroin priming over the first 3 months. Psychopharmacology 2004; 176: 109–14.
Shaham Y, Shalev U, Lu L, de Wit H, Stewart J . The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 2003; 168: 3–20.
Lu L, Shepard JD, Scott Hall F, Shaham Y . Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev 2003; 27: 457–91.
Wang X, Cen X, Lu L . Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol 2001; 432: 153–61.
O'Brien CP . A range of research-based pharmacotherapies for addiction. Science 1997; 278: 66–70.
Mendelson JH, Mello NK . Management of cocaine abuse and dependence. N Engl J Med 1996; 334: 965–72.
Tang YL, Wiste A, Mao PX, Hou YZ . Attitudes, knowledge, and perceptions of Chinese doctors toward drug abuse. J Subst Abuse Treat 2005; 29: 215–20.
Fok MS, Tsang WY . Development of an instrument measuring Chinese adolescent beliefs and attitudes towards substance abuse. J Clin Nurs 2005; 14: 986–94.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported in part by grants from the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, USA, the 985 Talent Program of Peking University (No 985-2-046-121 to Dr Lin Lu), the National Basic Research Program of China (No 20003CB 515400 to Dr Jie Shi), and the National Natural Science Foundation of China (No 30570576 to Dr Lin Lu).
Rights and permissions
About this article
Cite this article
Fang, Yx., Wang, Yb., Shi, J. et al. Recent trends in drug abuse in China. Acta Pharmacol Sin 27, 140–144 (2006). https://doi.org/10.1111/j.1745-7254.2006.00270.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00270.x
Keywords
This article is cited by
-
Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse
Neuroscience Bulletin (2022)
-
Unraveling the opioid actions of S-ketamine and R-ketamine: comment on Bonaventura et al.
Molecular Psychiatry (2021)
-
Application of the Chinese version of the addiction profile index (API) in drug users: an analysis of validity and measurement invariance across genders
Substance Abuse Treatment, Prevention, and Policy (2020)
-
Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, China
BMC Psychiatry (2017)
-
Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China
Scientific Reports (2017)